Johnson & Johnson

NYSE:JNJ   3:59:59 PM EDT
181.43
+1.99 (+1.11%)
Products

FDA Limits Use Of Janssen Covid-19 Vaccine To Certain Individuals

Published: 05/05/2022 23:08 GMT
Johnson & Johnson (JNJ) - FDA Limits Use of Janssen Covid-19 Vaccine to Certain Individuals.
FDA - Limited Authorized Use of Janssen Covid-19 Vaccine to Adults for Whom Other Authorized/approved Vaccines Are Not Accessible/clinically Appropriate.
FDA - Determined That Known & Potential Benefits of Janssen Covid-19 Vaccine Outweigh Known, Potential Risks for Individuals 18 Years of Age & Older.
FDA - Risk of Thrombosis With Thrombocytopenia Syndrome in Combination With Low Levels of Blood Platelets, Warrants Limiting Authorized Use Janssen Vaccine.
FDA - Limited Authorized Use of Janssen Covid-19 Vaccine to Who Elect to Receive Janssen Vaccine Because They Would Otherwise Not Receive Covid-19 Vaccine.